FDA Staff ‘Literally’ Up At Night Deciding 3-Year Exclusivity Requests

 
• By Brenda Sandburg
  
Complex decision
FDA is making complicated decisions about awarding three-year exclusivity to drug products • Source: Shutterstock

More from US FDA

More from Agency Leadership